DCSIMG
NIH Guidelines – Transition to Inhaler

AZMACORT Allows For A Convenient Transition From Nebulizer Therapy To Inhaler Therapy

Transition To Inhaler
  • For children aged 6 to 12 years, the usual recommended dosage of AZMACORT is 1 or 2 inhalations (75 or 150 mcg) given 3 to 4 times a day or 2 to 4 inhalations (150-300 mcg) BID. The maximum daily intake should not exceed 12 inhalations (900 mcg)

AZMACORT Inhalation Aerosol is indicated in the maintenance treatment of asthma as prophylactic therapy. AZMACORT is also indicated for asthma patients who require systemic corticosteroid administration, where adding AZMACORT may reduce or eliminate the need for the systemic corticosteroids.

AZMACORT is NOT indicated for the relief of acute bronchospasm.